{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:10:08Z","timestamp":1748358608871},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T00:00:00Z","timestamp":1470096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12640-016-9655-z","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T10:00:29Z","timestamp":1470132029000},"page":"698-714","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?"],"prefix":"10.1007","volume":"30","author":[{"given":"Patrycja","family":"Kleczkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Smaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Filip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Bujalska-Zadrozny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"9655_CR1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1530-0277.1995.tb01492.x","volume":"19","author":"ML Adams","year":"1995","unstructured":"Adams ML, Sewing BN, Chen J, Meyer ER, Cicero TJ (1995) Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol Clin Exp Res 19:195\u2013199","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0002-9343(01)01088-9","volume":"112","author":"G Addolorato","year":"2002","unstructured":"Addolorato G, Caputo F, Capristo E et al (2002) Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 112:226\u2013229","journal-title":"Am J Med"},{"key":"9655_CR3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00002826-200309000-00010","volume":"26","author":"G Addolorato","year":"2003","unstructured":"Addolorato G, Leggio L, Abenavoli L et al (2003) Suppression of alcohol delirium tremens by baclofen administration: a case report. Clin Neuropharmacol 26:258\u2013262","journal-title":"Clin Neuropharmacol"},{"key":"9655_CR4","first-page":"e213","volume":"276","author":"G Addolorato","year":"2006","unstructured":"Addolorato G, Leggio L, Abenavoli L et al (2006) Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 276:e213\u2013e278","journal-title":"Am J Med"},{"key":"9655_CR5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/alcalc\/agr017","volume":"46","author":"G Addolorato","year":"2011","unstructured":"Addolorato G, Leggio L, Ferrulli A et al (2011) Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol 46:312\u2013317","journal-title":"Alcohol Alcohol"},{"key":"9655_CR6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1530-0277.1994.tb00053.x","volume":"18","author":"B Adinoff","year":"1994","unstructured":"Adinoff B (1994) Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. Alcohol Clin Exp Res 18:873\u2013878","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fnins.2014.00140","volume":"8","author":"R Agabio","year":"2014","unstructured":"Agabio R, Colombo G (2014) GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci 8:140","journal-title":"Front Neurosci"},{"key":"9655_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0031-9384(91)90233-E","volume":"49","author":"A Agmo","year":"1991","unstructured":"Agmo A, Contreras JL, Paredes R (1991) Sexual behavior and copulatory thrusting patterns in male rabbits treated with GABA transaminase inhibitors. Physiol Behav 49:73\u201378","journal-title":"Physiol Behav"},{"key":"9655_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1471-4159.2009.06301.x","volume":"111","author":"L Alvarez-Jaimes","year":"2009","unstructured":"Alvarez-Jaimes L, Stouffer DG, Parsons LH (2009) Chronic ethanol treatment potentiates ethanol-induced increases in interstitial nucleus accumbens endocannabinoid levels in rats. J Neurochem 111:37\u201348","journal-title":"J Neurochem"},{"key":"9655_CR10","doi-asserted-by":"crossref","unstructured":"Amato L, Minozzi S, Vecchi S, Davoli M (2010) Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 3 CD005063","DOI":"10.1002\/14651858.CD005063.pub3"},{"key":"9655_CR11","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","volume":"156","author":"RF Anton","year":"1999","unstructured":"Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156:1758\u20131764","journal-title":"Am J Psychiatry"},{"key":"9655_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.jcp.0000130555.63254.73","volume":"24","author":"RF Anton","year":"2004","unstructured":"Anton RF, Pettinati H, Zweben A et al (2004) A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol 24:421\u2013428","journal-title":"J Clin Psychopharmacol"},{"key":"9655_CR13","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton RF, O\u2019Malley SS, Ciraulo DA et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003\u20132017","journal-title":"JAMA"},{"key":"9655_CR14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1176\/appi.ajp.2011.10101436","volume":"168","author":"RF Anton","year":"2011","unstructured":"Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK (2011) Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry 168:709\u2013717","journal-title":"Am J Psychiatry"},{"key":"9655_CR15","first-page":"8","volume":"38","author":"B Arbaizar","year":"2010","unstructured":"Arbaizar B, Diersen-Sotos T, G\u00f3mez-Acebo I, Llorca J (2010) Topiramate in the treatment of alcohol dependence: a meta-analysis. Actas Esp Psiquiatr 38:8\u201312","journal-title":"Actas Esp Psiquiatr"},{"key":"9655_CR16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0753-3322(92)90047-B","volume":"46","author":"D Bailly","year":"1992","unstructured":"Bailly D, Servant D, Blandin N, Beuscart R, Parquet PJ (1992) Effects of beta-blocking drugs in alcohol withdrawal: a double-blind comparative study with propranolol and diazepam. Biomed Pharmacother 46:419\u2013424","journal-title":"Biomed Pharmacother"},{"key":"9655_CR17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugalcdep.2006.08.016","volume":"87","author":"JR Baker","year":"2007","unstructured":"Baker JR, Jatlow P, McCance-Katz EF (2007) Disulfiram effects on responses to intravenous cocaine administration. Drug Alcohol Depend 87:202\u2013209","journal-title":"Drug Alcohol Depend"},{"key":"9655_CR18","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1360-0443.2008.02355.x","volume":"103","author":"DA Baltieri","year":"2008","unstructured":"Baltieri DA, Daro FR, Ribeiro PL, de Andrade AG (2008) Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103:2035\u20132044","journal-title":"Addiction"},{"key":"9655_CR19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF02245942","volume":"118","author":"RL Barrett","year":"1995","unstructured":"Barrett RL, Wiley JL, Balster RL, Martin BR (1995) Pharmacological specificity of Delta9-tetrahydrocannabinol discrimination in rats. Psychopharmacology 118:419\u2013424","journal-title":"Psychopharmacology"},{"key":"9655_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM197208032870501","volume":"287","author":"P Beaconsfield","year":"1972","unstructured":"Beaconsfield P, Ginsburg J, Rainsbury R (1972) Marihuana smoking: cardiovascular effects in man and possible mechanisms. N Engl J Med 287:209\u2013212","journal-title":"N Engl J Med"},{"key":"9655_CR21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0741-8329(97)87949-9","volume":"14","author":"HC Becker","year":"1997","unstructured":"Becker HC, Diaz-Granados JL, Weathersby RT (1997) Repeated ethanol withdrawal experience increases the severity and duration of subsequent withdrawal seizures in mice. Alcohol 14:319\u2013326","journal-title":"Alcohol"},{"key":"9655_CR22","first-page":"12","volume":"45","author":"IB Belousov","year":"2005","unstructured":"Belousov IB, Egorova NA, Sidorenko BA, Ivleva AIu, Ageev FT, Ole\u012dnikov VE (2005) Confirmation of safety and therapeutic effect of betaxolol in the treatment of mild and moderate hypertension in general medical practice. Kardiologia 45:12\u201317","journal-title":"Kardiologia"},{"key":"9655_CR23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/archpsyc.1991.01810280099018","volume":"48","author":"C Benkelfat","year":"1991","unstructured":"Benkelfat C, Murphy DL, Hill JL, George DT, Nutt D, Linnoila M (1991) Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry 48:383","journal-title":"Arch Gen Psychiatry"},{"key":"9655_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugalcdep.2005.10.008","volume":"83","author":"A Bisaga","year":"2006","unstructured":"Bisaga A, Evans SM (2006) The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug Alcohol Depend 83:25\u201332","journal-title":"Drug Alcohol Depend"},{"key":"9655_CR25","doi-asserted-by":"crossref","first-page":"148108","DOI":"10.1111\/acer.12411","volume":"38","author":"JC Blodgett","year":"2014","unstructured":"Blodgett JC, Del Re AC, Maisel NC, Finney JW (2014) A meta-analysis of topiramate\u2019s effects for individuals with alcohol use disorder. Alcohol Clin Exp Res 38:148108","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0278-5846(01)00234-2","volume":"26","author":"V Bozikas","year":"2002","unstructured":"Bozikas V, Petrikis P, Gamvrula K, Savvidou I, Karavatos A (2002) Treatment of alcohol withdrawal with gabapentin. Prog Neuropsychopharmacol Biol Psychiatry 26:197\u2013199","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9655_CR27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0306-4522(01)00210-X","volume":"104","author":"D Braida","year":"2001","unstructured":"Braida D, Pozzi M, Cavallini R, Sala M (2001) Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Neurosci 104:923\u2013926","journal-title":"Neurosci"},{"key":"9655_CR28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2004.10.043","volume":"506","author":"D Braida","year":"2004","unstructured":"Braida D, Iosue S, Pegorini S, Sala M (2004) Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats. Eur J Pharmacol 506:63\u201369","journal-title":"Eur J Pharmacol"},{"key":"9655_CR29","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/sj.npp.1300706","volume":"30","author":"GR Breese","year":"2005","unstructured":"Breese GR, Overstreet DH, Knapp DJ, Navarro M (2005) Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology 30:1662\u20131669","journal-title":"Neuropsychopharmacology"},{"key":"9655_CR30","first-page":"1737","volume-title":"Effects of beta adrenergic blockade on marijuana induced tachycardia","author":"RP Bright","year":"1971","unstructured":"Bright RP, Kiplinger GF, Brown D, Philips J, Forney RB (1971) Effects of beta adrenergic blockade on marijuana induced tachycardia. National Academy of Science-National Research Council, Reported to the committee on Problems of Drug Dependence, p 1737"},{"key":"9655_CR31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.neuroscience.2008.09.010","volume":"157","author":"SP Brooks","year":"2008","unstructured":"Brooks SP, Croft AP, Norman G, Shaw SG, Little HJ (2008) Nimodipine prior to alcohol withdrawal prevents memory deficits during the abstinence phase. Neuroscience 157:376\u2013384","journal-title":"Neuroscience"},{"key":"9655_CR32","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1530-0277.2008.00706.x","volume":"32","author":"KJ Brower","year":"2008","unstructured":"Brower KJ, Myra Kim H, Strobbe S, Karam-Hage MA, Consens F, Zucker RA (2008) A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res 32:1429\u20131438","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR33","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1530-0277.2009.01024.x","volume":"33","author":"SE Brown","year":"2009","unstructured":"Brown SE, Carmody TJ, Schmitz JM et al (2009) A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res 33:1863\u20131869","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainresbull.2016.04.006","volume":"125","author":"R Camarini","year":"2016","unstructured":"Camarini R, Pautassi RM (2016) Behavioral sensitization to ethanol: neural basis and factors that influence its acquisition and expression. Brain Res Bull 125:53\u201378","journal-title":"Brain Res Bull"},{"key":"9655_CR35","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2174\/138161210791516468","volume":"16","author":"F Caputo","year":"2010","unstructured":"Caputo F, Bernardi M (2010) Medications acting on the GABA system in the treatment of alcoholic patients. Curr Pharm Des 16:2118\u20132125","journal-title":"Curr Pharm Des"},{"key":"9655_CR36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.euroneuro.2010.12.005","volume":"21","author":"F Caputo","year":"2011","unstructured":"Caputo F, Francini S, Brambilla R et al (2011) Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity. Eur Neuropsychopharmacol 21:450\u2013456","journal-title":"Eur Neuropsychopharmacol"},{"key":"9655_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10550490802408936","volume":"18","author":"KM Carpenter","year":"2009","unstructured":"Carpenter KM, McDowell D, Brooks DJ, Cheng WY, Levin FR (2009) A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict 18:53\u201364","journal-title":"Am J Addict"},{"key":"9655_CR38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2011.06.008","volume":"500","author":"AF Carvalho","year":"2011","unstructured":"Carvalho AF, Van Bockstaele EJ (2011) Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion. Neurosci Lett 500:82\u201385","journal-title":"Neurosci Lett"},{"key":"9655_CR39","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s00259-013-2456-1","volume":"40","author":"J Ceccarini","year":"2013","unstructured":"Ceccarini J, Casteels C, Koole M, Bormans G, Van Laere K (2013) Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study. Eur J Nucl Med Mol Imaging 40:1582\u20131594","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9655_CR40","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1523\/JNEUROSCI.0849-13.2014","volume":"34","author":"J Ceccarini","year":"2014","unstructured":"Ceccarini J, Hompes T, Verhaeghen A et al (2014) Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence. J Neurosci 34:2822\u20132831","journal-title":"J Neurosci"},{"key":"9655_CR41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.pnpbp.2010.12.009","volume":"35","author":"IK Celikyurt","year":"2011","unstructured":"Celikyurt IK, Kayir H, Ulak G, Erden FB, Ulusoy GK, Uzbay TI (2011) Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats. Prog Neuropsychopharmacol Biol Psychiatry 35:528\u2013536","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9655_CR42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1037\/0022-006X.70.1.67","volume":"70","author":"L Chassin","year":"2002","unstructured":"Chassin L, Pitts SC, Prost J (2002) Binge drinking trajectories from adolesence to emerging adulthood in a high-risk sample: predictors and substance abuse outcomes. J Consult Clin Psychol 70:67\u201378","journal-title":"J Consult Clin Psychol"},{"key":"9655_CR43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/alcalc\/35.6.587","volume":"35","author":"J Chick","year":"2000","unstructured":"Chick J, Anton R, Checinski K et al (2000) A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 35:587\u2013593","journal-title":"Alcohol Alcohol"},{"key":"9655_CR45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2007.12.002","volume":"89","author":"CS Chung","year":"2008","unstructured":"Chung CS, Wang J, Wehman M, Rhoads DE (2008) Severity of alcohol withdrawal symptoms depends on developmental stage of Long-Evans rats. Pharmacol Biochem Behav 89:137\u2013144","journal-title":"Pharmacol Biochem Behav"},{"key":"9655_CR46","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0196-0644(97)70059-3","volume":"30","author":"TR Coomes","year":"1997","unstructured":"Coomes TR, Smith SW (1997) Successful use of propofol in refractory delirium tremens. Ann Emerg Med 30:825\u2013828","journal-title":"Ann Emerg Med"},{"key":"9655_CR47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-010-1875-y","volume":"211","author":"ZD Cooper","year":"2010","unstructured":"Cooper ZD, Haney M (2010) Opioid antagonism enhances marijuana\u2019s effects in heavy marijuana smokers. Psychopharmacology 211:141\u2013148","journal-title":"Psychopharmacology"},{"key":"9655_CR48","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0024-3205(98)00341-5","volume":"63","author":"J Corchero","year":"1998","unstructured":"Corchero J, Garc\u00eda-Gil L, Manzanares J, Fern\u00e1ndez-Ruiz JJ, Fuentes JA, Ramos JA (1998) Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats. Life Sci 63:843\u2013850","journal-title":"Life Sci"},{"key":"9655_CR49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(90)90414-D","volume":"36","author":"B Costall","year":"1990","unstructured":"Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990) Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol Biochem Behav 36:339\u2013344","journal-title":"Pharmacol Biochem Behav"},{"key":"9655_CR50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0301-0082(99)00031-3","volume":"60","author":"A Dahchour","year":"2000","unstructured":"Dahchour A, De Witte P (2000) Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate. Prog Neurobiol 60:343\u2013362","journal-title":"Prog Neurobiol"},{"key":"9655_CR51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cpt1975183298","volume":"18","author":"WS Dalton","year":"1975","unstructured":"Dalton WS, Martz R, Lemberger L, Rodda BE, Forney RB (1975) Effects of marihuana combined with secobarbital. Clin Pharmacol Ther 18:298\u2013304","journal-title":"Clin Pharmacol Ther"},{"key":"9655_CR52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1940-0640-8-12","volume":"8","author":"AC Re Del","year":"2013","unstructured":"Del Re AC, Gordon AJ, Lembke A, Harris AH (2013) Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration. Addict Sci Clin Pract 8:12","journal-title":"Addict Sci Clin Pract"},{"key":"9655_CR53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/alcalc\/agh187","volume":"40","author":"A Desousa","year":"2005","unstructured":"Desousa A (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 40:545\u2013548","journal-title":"Alcohol Alcohol"},{"key":"9655_CR54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15288\/jsad.2008.69.5","volume":"69","author":"DM Donovan","year":"2008","unstructured":"Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M (2008) Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. J Stud Alcohol Drugs 69:5\u201313","journal-title":"J Stud Alcohol Drugs"},{"key":"9655_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2009.09.004","volume":"90","author":"E Drews","year":"2010","unstructured":"Drews E, Zimmer A (2010) Modulation of alcohol and nicotine responses through the endogenous opioid system. Prog Neurobiol 90:1\u201315","journal-title":"Prog Neurobiol"},{"key":"9655_CR56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2006.08.051","volume":"550","author":"N Egashira","year":"2006","unstructured":"Egashira N, Matsuda T, Koushi E, Mishima K, Iwasaki K, Shoyama Y, Fujiwara M (2006) Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice. Eur J Pharmacol 550:117\u2013122","journal-title":"Eur J Pharmacol"},{"key":"9655_CR57","first-page":"17","volume":"29","author":"A Elkashef","year":"2008","unstructured":"Elkashef A, Vocci F, Huestis M, Haney M, Budney A, Gruber A, El-Guebaly N (2008) Marijuana neurobiology and treatment. Subst Abuse 29:17\u201329","journal-title":"Marijuana neurobiology and treatment. Subst Abuse"},{"key":"9655_CR58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/oxfordjournals.alcalc.a045088","volume":"26","author":"F Fadda","year":"1991","unstructured":"Fadda F, Garau B, Marchei F, Colombo G, Gessa GL (1991) MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats. Alcohol Alcohol 26:107\u2013110","journal-title":"Alcohol Alcohol"},{"key":"9655_CR59","first-page":"100","volume":"31","author":"D Falk","year":"2008","unstructured":"Falk D, Yi H, Hiller-Sturmh\u00f6fel S (2008) An epidemiologicanalysis of co-occuring alcohol and other drug use and disorders. Alcohol Res Curr Rev 31:100\u2013110","journal-title":"Alcohol Res Curr Rev"},{"key":"9655_CR60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.physbeh.2008.05.020","volume":"95","author":"JM Farook","year":"2008","unstructured":"Farook JM, Krazem A, Lewis B, Morrell DJ, Littleton JM, Barron S (2008) Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice. Physiol Behav 95:267\u2013270","journal-title":"Physiol Behav"},{"key":"9655_CR61","first-page":"495","volume":"2","author":"SE File","year":"1993","unstructured":"File SE, Andrews N, al-Farhan M, Wu PY (1993) The role of 5-HT in the anxiogenic effects of acute ethanol withdrawal and in the long-lasting cognitive deficits. Alcohol Alcohol 2:495\u2013499","journal-title":"Alcohol Alcohol"},{"key":"9655_CR62","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1530-0277.2008.00680.x","volume":"32","author":"G Fl\u00f3rez","year":"2008","unstructured":"Fl\u00f3rez G, Garc\u00eda-Portilla P, Alvarez S, Saiz PA, Nogueiras L, Bobes J (2008) Using topiramate or naltrexone for the treatment of\u00a0alcohol-dependent patients. Alcohol Clin Exp Res 32:1251","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2013.8268","volume":"310","author":"EB Foa","year":"2013","unstructured":"Foa EB, Yusko DA, McLean CP et al (2013) Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA 310:488\u2013495","journal-title":"JAMA"},{"key":"9655_CR64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/qjmed\/90.4.253","volume":"90","author":"A Foy","year":"1997","unstructured":"Foy A, Kay J, Taylor A (1997) The course of alcohol withdrawal in a general hospital. QJM 90:253\u2013261","journal-title":"QJM"},{"key":"9655_CR65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s004060170039","volume":"251","author":"M Frantz","year":"2001","unstructured":"Frantz M, Dlabal H, Kunz S, Ulferts J, Gruppe H, Gallhofer B (2001) Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study. Eur Arch Psychiatry Clin Neurosci 251:185\u2013192","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"9655_CR66","unstructured":"Frewen A, Montebello ME, Baillie A, Rea F (2007) Effects of mirtazapine on withdrawal from dependent cannabis use. Proceedings of the 69th Annual Scientific Meeting of the College on Problems of Drug Dependence; Quebec City, 2007, p. 21"},{"key":"9655_CR67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0091-3057(90)90174-G","volume":"35","author":"JC Froehlich","year":"1990","unstructured":"Froehlich JC, Harts J, Lumeng L, Li TK (1990) Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 35:385\u2013390","journal-title":"Pharmacol Biochem Behav"},{"key":"9655_CR68","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4088\/JCP.v68n1108","volume":"68","author":"FA Furieri","year":"2007","unstructured":"Furieri FA, Nakamura-Palacios EM (2007) Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 68:1691\u20131700","journal-title":"J Clin Psychiatry"},{"key":"9655_CR69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/alcalc\/agn122","volume":"44","author":"JC Garbutt","year":"2009","unstructured":"Garbutt JC, Osborne M, Gallop R et al (2009) Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol Alcohol 44:293\u2013300","journal-title":"Alcohol Alcohol"},{"key":"9655_CR70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mi.9.4.6","volume":"9","author":"M Gaval-Cruz","year":"2009","unstructured":"Gaval-Cruz M, Weinshenker D (2009) Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol Interv 9:175\u2013187","journal-title":"Mol Interv"},{"key":"9655_CR71","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/archpsyc.1973.01750360034004","volume":"28","author":"JR Gerrein","year":"1973","unstructured":"Gerrein JR, Rosenberg CM, Manohar V (1973) Disulfiram maintenance in outpatient treatment of alcoholism. Arch Gen Psychiatry 28:798\u2013802","journal-title":"Arch Gen Psychiatry"},{"key":"9655_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2011.06.013","volume":"225","author":"M Ghiasvand","year":"2011","unstructured":"Ghiasvand M, Rezayof A, Ahmadi S, Zarrindast MR (2011) \u03b21-noradrenergic system of the central amygdala is involved in state-dependent memory induced by a cannabinoid agonist, WIN55,212-2, in rat. Behav Brain Res 225:1\u20136","journal-title":"Behav Brain Res"},{"key":"9655_CR73","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1523\/JNEUROSCI.22-03-01146.2002","volume":"22","author":"S Ghozland","year":"2002","unstructured":"Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002) Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 22:1146\u20131154","journal-title":"J Neurosci"},{"key":"9655_CR74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)03344-9","volume":"954","author":"S Gonzalez","year":"2002","unstructured":"Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Di Marzo V, Ramos JA (2002) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954:73\u201381","journal-title":"Brain Res"},{"key":"9655_CR75","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1530-0277.1994.tb00034.x","volume":"18","author":"KA Grant","year":"1994","unstructured":"Grant KA, Hellevuo K, Tabakoff B (1994) The 5-HT3 antagonist MDL-72222 exacerbates ethanol withdrawal seizures in mice. Alcohol Clin Exp Res 18:410\u2013414","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0376-8716(99)00128-3","volume":"59","author":"MK Greenwald","year":"2000","unstructured":"Greenwald MK, Stitzer ML (2000) Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend 59:261\u2013275","journal-title":"Drug Alcohol Depend"},{"key":"9655_CR77","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.euroneuro.2013.02.006","volume":"23","author":"A Gual","year":"2013","unstructured":"Gual A, He Y, Torup L, van den Brink W, Mann K (2013) A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol 23:1432\u20131442","journal-title":"Eur Neuropsychopharmacol"},{"key":"9655_CR78","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0277-9536(91)90216-Y","volume":"33","author":"C Gudex","year":"1991","unstructured":"Gudex C (1991) Adverse effects of benzodiazepines. Soc Sci Med 33:587\u2013596","journal-title":"Soc Sci Med"},{"key":"9655_CR79","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s12325-012-0061-5","volume":"29","author":"R Guglielmo","year":"2012","unstructured":"Guglielmo R, Martinotti G, Clerici M, Janiri L (2012) Pregabalin for alcohol dependence: a critical review of the literature. Adv Ther 29:947\u2013957","journal-title":"Adv Ther"},{"key":"9655_CR80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03161171","volume":"2","author":"JB Hack","year":"2006","unstructured":"Hack JB, Hoffmann RS, Nelson LS (2006) Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol 2:55\u201360","journal-title":"J Med Toxicol"},{"key":"9655_CR81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09595230500126698","volume":"24","author":"WD Hall","year":"2005","unstructured":"Hall WD, Lynskey M (2005) Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev 24:39\u201348","journal-title":"Drug Alcohol Rev"},{"key":"9655_CR82","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.npp.1301243","volume":"32","author":"M Haney","year":"2007","unstructured":"Haney M (2007) Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers. Neuropsychopharmacology 32:1391\u20131403","journal-title":"Neuropsychopharmacology"},{"key":"9655_CR83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00213-002-1279-8","volume":"166","author":"M Haney","year":"2003","unstructured":"Haney M, Bisage A, Foltin RW (2003) Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology 166:77\u201385","journal-title":"Psychopharmacology"},{"key":"9655_CR84","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.npp.1300310","volume":"29","author":"M Haney","year":"2004","unstructured":"Haney M, Hart CL, Vosburg SK et al (2004) Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 29:158\u2013170","journal-title":"Neuropsychopharmacology"},{"key":"9655_CR85","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1592\/phco.29.7.875","volume":"29","author":"CE Hayner","year":"2009","unstructured":"Hayner CE, Wuestefeld NL, Bolton PJ (2009) Phenobarbital treatment in a patient with resistant alcohol withdrawal syndrome. Pharmacotherapy 29:875\u2013878","journal-title":"Pharmacotherapy"},{"key":"9655_CR86","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/npp.2013.272","volume":"39","author":"M Heilig","year":"2014","unstructured":"Heilig M (2014) Acamprosate: an alcoholism treatment that may not be what we thought. Neuropsychopharmacology 39:781\u2013782","journal-title":"Neuropsychopharmacology"},{"key":"9655_CR87","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","volume":"21","author":"P Hein\u00e4l\u00e4","year":"2001","unstructured":"Hein\u00e4l\u00e4 P, Alho H, Kiianmaa K, L\u00f6nnqvist J, Kuoppasalmi K, Sinclair JD (2001) Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol 21:287\u2013292","journal-title":"J Clin Psychopharmacol"},{"key":"9655_CR88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1530-0277.1998.tb03623.x","volume":"22","author":"A Helander","year":"1998","unstructured":"Helander A (1998) Monitoring relapse drinking during disulfiram therapy by assay of urinary 5-hydroxytryptophol. Alcohol Clin Exp Res 22:111\u2013114","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR89","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ajem.2009.10.010","volume":"29","author":"GW Hendey","year":"2011","unstructured":"Hendey GW, Dery RA, Barnes RL, Snowden B, Mentler P (2011) A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal. Am J Emerg Med 29:382\u2013385","journal-title":"Am J Emerg Med"},{"key":"9655_CR90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s002130050688","volume":"139","author":"D Hersh","year":"1998","unstructured":"Hersh D, Van Kirk JR, Kranzler HR (1998) Naltrexone treatment of comorbid alcohol and cocaine use disorders. Psychopharmacology 139:44\u201352","journal-title":"Psychopharmacology"},{"key":"9655_CR91","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/PCC.08l00714","volume":"11","author":"M Hertzman","year":"2009","unstructured":"Hertzman M, Patt IS, Spielman LA (2009) Open-label trial of acamprostae as a treatment for anxiety. Prim Care Companion J Clin Psychiatry 11:267","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"9655_CR92","first-page":"793","volume":"19","author":"EC Hoff","year":"1955","unstructured":"Hoff EC (1955) The use of disulfiram (antabuse) in the comprehensive therapy of a group of 1,020 alcoholics. Conn State Med J 19:793\u2013798","journal-title":"Conn State Med J"},{"key":"9655_CR93","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/bcp.12023","volume":"77","author":"SD Hood","year":"2014","unstructured":"Hood SD, Norman A, Hince DA, Melichar JK, Hulse GK (2014) Benzodiazepine dependence and its treatment with low dose flumazenil. Br J Clin Pharmacol 77:285\u2013294","journal-title":"Br J Clin Pharmacol"},{"key":"9655_CR94","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archinte.1989.00390050075015","volume":"149","author":"RI Horwitz","year":"1989","unstructured":"Horwitz RI, Gottlieb LD, Kraus ML (1989) The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. Arch Intern Med 149:1089\u20131093","journal-title":"Arch Intern Med"},{"key":"9655_CR95","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.ajem.2013.08.044","volume":"32","author":"DW Hughes","year":"2014","unstructured":"Hughes DW, Vanwert E, Lepori L, Adams BD (2014) Propofol for benzodiazepine-refractory alcohol withdrawal in a non-mechanically ventilated patient. Am J Emerg Med 32:e113\u2013e114","journal-title":"Am J Emerg Med"},{"key":"9655_CR96","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.phrs.2005.05.012","volume":"52","author":"P Huguelet","year":"2005","unstructured":"Huguelet P, Morand-Collomb S (2005) Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse. Pharmacol Res 52:392\u2013394","journal-title":"Pharmacol Res"},{"key":"9655_CR97","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/2045125313512324","volume":"4","author":"B Imbert","year":"2014","unstructured":"Imbert B, Labrune N, Lancon C, Simon N (2014) Baclofen in the management of cannabis dependence syndrome. Ther Adv Psychopharmacol 4:50\u201352","journal-title":"Ther Adv Psychopharmacol"},{"key":"9655_CR98","first-page":"328","volume":"94","author":"TU J\u00e4rbe","year":"1988","unstructured":"J\u00e4rbe TU, Hiltunen AJ (1988) Limited stimulus generalization between delta 9-THC and diazepam in pigeons and gerbils. Psychopharmacology 94:328\u2013331","journal-title":"Psychopharmacology"},{"key":"9655_CR99","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00426779","volume":"54","author":"TU J\u00e4rbe","year":"1977","unstructured":"J\u00e4rbe TU, Ohlin GC (1977) Stimulus effects of delta(9)-THC and its interaction with naltrexone and catecholamine blockers in rats. Psychopharmacology 54:193\u2013195","journal-title":"Psychopharmacology"},{"key":"9655_CR100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ejpain.2009.11.008","volume":"14","author":"T Jochum","year":"2010","unstructured":"Jochum T, Boettger MK, Burkhardt C, Juckel G, Bar KJ (2010) Increased pain sensitivity in alcohol withdrawal syndrome. Eur J Pain 14:713\u2013718","journal-title":"Eur J Pain"},{"key":"9655_CR101","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130000371","volume":"149","author":"BA Johnson","year":"2000","unstructured":"Johnson BA, Ait-Daoud N (2000) Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology 149:327\u2013344","journal-title":"Psychopharmacology"},{"key":"9655_CR102","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2174\/138161210791516404","volume":"16","author":"BA Johnson","year":"2010","unstructured":"Johnson BA, Ait-Daoud N (2010) Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients. Curr Pharm Des 16:2103\u20132112","journal-title":"Curr Pharm Des"},{"key":"9655_CR103","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","volume":"361","author":"BA Johnson","year":"2003","unstructured":"Johnson BA, Ait-Daoud N, Bowden CL et al (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361:1677\u20131685","journal-title":"Lancet"},{"key":"9655_CR104","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","volume":"298","author":"BA Johnson","year":"2007","unstructured":"Johnson BA, Rosenthal N, Capece JA et al (2007) Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298:1641\u20131651","journal-title":"JAMA"},{"key":"9655_CR105","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00000542-197506000-00009","volume":"42","author":"RE Johnstone","year":"1975","unstructured":"Johnstone RE, Lief PL, Kulp RA, Smith TC (1975) Combination of delta-9-tetrahydrocannabinol with oxymorphone or pentobarbital: effects on ventilator control and cardiovascular dynamics. Anesthesiology 42:674\u2013684","journal-title":"Anesthesiology"},{"key":"9655_CR106","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-003-1693-6","volume":"173","author":"Z Justinova","year":"2004","unstructured":"Justinova Z, Tanda G, Munzar P, Goldberg S (2004) The opioid antagonist naltrexone reduces the reinforcing effects of 9-tetrahydrocannabinol (THC) in squirrel monkeys. Psychopharmacology 173:186\u2013194","journal-title":"Psychopharmacology"},{"key":"9655_CR107","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00417-002-0614-4","volume":"241","author":"D Kamal","year":"2003","unstructured":"Kamal D, Garway-Heath D, Ruben S et al (2003) Results of the betaxolol versus placebo treatment trial in ocular hypertension. Graefes Arch Clin Exp Ophthalmol 241:196\u2013203","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9655_CR108","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/JCP.0b013e3180ca86e5","volume":"27","author":"KM Kampman","year":"2007","unstructured":"Kampman KM, Pettinati HM, Lynch KG et al (2007) A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol 27:344\u2013351","journal-title":"J Clin Psychopharmacol"},{"key":"9655_CR109","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2013.05.026","volume":"133","author":"KM Kampman","year":"2013","unstructured":"Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O\u2019Brien CP (2013) A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend 133:94\u201399","journal-title":"Drug Alcohol Depend"},{"key":"9655_CR110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/alcalc\/agn052","volume":"43","author":"H Kayir","year":"2008","unstructured":"Kayir H, Uzbay T (2008) Effects of clozapine on ethanol withdrawal syndrome in rats. Alcohol Alcohol 43:619\u2013625","journal-title":"Alcohol Alcohol"},{"key":"9655_CR111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40261-013-0158-x","volume":"34","author":"GM Keating","year":"2014","unstructured":"Keating GM (2014) Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clin Drug Investig 34:63\u201380","journal-title":"Clin Drug Investig"},{"key":"9655_CR112","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1530-0277.1991.tb00546.x","volume":"15","author":"AC King","year":"1991","unstructured":"King AC, Errico AL, Parsons OA, Lovallo WR (1991) Blood pressure dysregulation associated with alcohol withdrawal. Alcohol Clin Exp Res 15:478\u2013482","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR113","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0741-8329(96)00029-8","volume":"13","author":"AC King","year":"1996","unstructured":"King AC, Bernardy NC, Parsons OA, Lovallo WR (1996) Hemodynamic alterations in alcohol-related transitory hypertension. Alcohol 13:387\u2013393","journal-title":"Alcohol"},{"key":"9655_CR114","first-page":"408","volume":"22","author":"AD Korczyn","year":"1982","unstructured":"Korczyn AD, Eshel Y (1982) Mydriasis induced by tetrahydrocannabinol (THC) in rats. Invest Ophthalmol Visual Sci 22:408\u2013410","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"9655_CR115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0741-8329(93)90022-G","volume":"10","author":"W Kostowski","year":"1993","unstructured":"Kostowski W, Dyr W, Krzascik P (1993) The abilities of 5-HT3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats. Alcohol 10:369\u2013373","journal-title":"Alcohol"},{"key":"9655_CR116","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2174\/138161210791516431","volume":"16","author":"H Krampe","year":"2010","unstructured":"Krampe H, Ehrenreich H (2010) Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des 16:2076\u20132090","journal-title":"Curr Pharm Des"},{"key":"9655_CR117","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1176\/appi.ajp.2013.13081014","volume":"171","author":"HR Kranzler","year":"2014","unstructured":"Kranzler HR, Covault J, Feinn R et al (2014) Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am J Psychiatry 171:445\u2013452","journal-title":"Am J Psychiatry"},{"key":"9655_CR118","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM198510103131501","volume":"313","author":"ML Kraus","year":"1985","unstructured":"Kraus ML, Gottlieb LD, Horwitz RI, Anscher M (1985) Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 313:905\u2013909","journal-title":"N Engl J Med"},{"key":"9655_CR119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1176\/ajp.153.1.83","volume":"153","author":"JH Krystal","year":"1996","unstructured":"Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS (1996) Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry 153:83\u201392","journal-title":"Am J Psychiatry"},{"key":"9655_CR120","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa011127","volume":"345","author":"JH Krystal","year":"2001","unstructured":"Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345:1734\u20131739","journal-title":"N Engl J Med"},{"key":"9655_CR121","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/sj.npp.1300994","volume":"31","author":"JH Krystal","year":"2006","unstructured":"Krystal JH, Madonick S, Perry E et al (2006) Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism. Neuropsychopharmacology 31:1793\u20131800","journal-title":"Neuropsychopharmacology"},{"key":"9655_CR122","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TA Kurko","year":"2015","unstructured":"Kurko TA, Saastamoinen LK, Tahkapaa S et al (2015) Long-term use of benzodiazepines: definitions, prevalence and usage patterns\u2014a systematic review of register-based studies. Eur Psychiatry 30:1037\u20131047","journal-title":"Eur Psychiatry"},{"key":"9655_CR123","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/alcalc\/agm136","volume":"43","author":"E Laaksonen","year":"2008","unstructured":"Laaksonen E, Koski-Jannes A, Salaspuro M, Ahtinen H, Alho H (2008) A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 43:53\u201361","journal-title":"Alcohol Alcohol"},{"key":"9655_CR124","first-page":"242","volume":"140","author":"RB Lacoursiere","year":"1983","unstructured":"Lacoursiere RB, Swatek R (1983) Adverse interaction between disulfiram and marijuana: a case report. Am J Psychiatry 140:242\u2013244","journal-title":"Am J Psychiatry"},{"key":"9655_CR125","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1471-4159.2004.02725.x","volume":"91","author":"P Laeng","year":"2004","unstructured":"Laeng P, Pitts RL, Lemire AL et al (2004) The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 91:238\u2013251","journal-title":"J Neurochem"},{"key":"9655_CR126","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.pnpbp.2007.09.021","volume":"32","author":"L Leggio","year":"2008","unstructured":"Leggio L, Kenna GA, Swift RM (2008) New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Prog Neuropsychopharmacol Biol Psychiatry 32:1106\u20131117","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9655_CR127","first-page":"23","volume":"7","author":"DM Li","year":"1980","unstructured":"Li DM (1980) The lack of beta-adrenoceptor involvement in the cardiac action of delta 1-tetrahydrocannabinol in rats. Clin Exp Pharmacol Physiol 7:23\u201329","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9655_CR128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2004.10.005","volume":"29","author":"J Liappas","year":"2005","unstructured":"Liappas J, Paparrigopoulos T, Tzavellas E, Rabavilas A (2005) Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. Prog Neuropsychopharmacol Biol Psychiatry 29:55\u201360","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9655_CR129","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.drugalcdep.2013.06.032","volume":"133","author":"S Likhitsathian","year":"2013","unstructured":"Likhitsathian S, Uttawichai K, Booncharoen H, Wittayanookulluk A, Angkurawaranon C, Srisurapanont M (2013) Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial. Drug Alcohol Depend 133:440\u2013446","journal-title":"Drug Alcohol Depend"},{"key":"9655_CR130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2014.07.016","volume":"143","author":"JA Lile","year":"2014","unstructured":"Lile JA, Hays LR, Kelly TH (2014) Separate and combined effects of the GABAA positive allosteric modulator diazepam and \u03949-THC in humans discriminating \u03949-THC. Drug Alcohol Depend 143:141\u2013148","journal-title":"Drug Alcohol Depend"},{"key":"9655_CR131","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00003246-198803000-00018","volume":"16","author":"WC Lineaweaver","year":"1988","unstructured":"Lineaweaver WC, Anderson K, Hing DN (1988) Massive doses of midazolam infusion for delirium tremens without respiratory depression. Crit Care Med 16:294\u2013295","journal-title":"Crit Care Med"},{"key":"9655_CR132","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0149-7634(85)90034-X","volume":"9","author":"RG Lister","year":"1985","unstructured":"Lister RG (1985) The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 9:87\u201394","journal-title":"Neurosci Biobehav Rev"},{"key":"9655_CR133","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02244612","volume":"100","author":"JM Littleton","year":"1990","unstructured":"Littleton JM, Little HJ, Whittington MA (1990) Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644. Psychopharmacology 100:387\u2013392","journal-title":"Psychopharmacology"},{"key":"9655_CR134","first-page":"A4807","volume":"61","author":"K Lorentzen","year":"2014","unstructured":"Lorentzen K, Lauritsen AO, Bendtsen AO (2014) Use of propofol infusion in alcohol withdrawal-induced refractory delirium tremens. Dan Med J 61:A4807","journal-title":"Dan Med J"},{"key":"9655_CR135","first-page":"114","volume":"21","author":"DM Lovinger","year":"1997","unstructured":"Lovinger DM (1997) Serotonin\u2019s role in alcohol\u2019s effects on the brain. Alcohol Health Res World 21:114\u2013120","journal-title":"Alcohol Health Res World"},{"key":"9655_CR136","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-4615-2470-0_14","volume-title":"Alcohol, cell membranes and signal transduction in brain","author":"Lovinger DM, Peoples RW","year":"1993","unstructured":"Lovinger DM, Peoples RW (1993) Actions of alcohols and other sedative\/hypnotic compounds on cation channels associated with glutamate and 5-HT3 receptors. In: Alling C, Diamond I, Leslie SW, Sun GY, Wood WG (eds) Alcohol, cell membranes and signal transduction in brain. Plenum Press, New York, pp 157\u2013168"},{"key":"9655_CR137","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.alcohol.2007.03.008","volume":"41","author":"DM Lovinger","year":"2007","unstructured":"Lovinger DM, Homanics GE (2007) Tonic for what ails us? High-affinity GABAA receptors and alcohol. Alcohol 41:139\u2013143","journal-title":"Alcohol"},{"key":"9655_CR138","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jhm.928","volume":"6","author":"JE Lyon","year":"2011","unstructured":"Lyon JE, Khan RA, Gessert CE, Larson PM, Renier CM (2011) Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial. J Hosp Med 6:469\u2013474","journal-title":"J Hosp Med"},{"key":"9655_CR139","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0972-6748.77641","volume":"19","author":"R Mahajan","year":"2010","unstructured":"Mahajan R, Singh R, Bansal PD, Bala R (2010) Use of propofol as adjuvant therapy in refractory delirium tremens. Ind Psychiatry J 19:58\u201359","journal-title":"Ind Psychiatry J"},{"key":"9655_CR140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","volume":"108","author":"NC Maisel","year":"2013","unstructured":"Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW (2013) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108:275\u2013293","journal-title":"Addiction"},{"key":"9655_CR141","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0741-8329(00)00114-2","volume":"22","author":"R Malcolm","year":"2000","unstructured":"Malcolm R, Roberts JS, Wang W, Myrick H, Anton RF (2000) Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol 22:159\u2013164","journal-title":"Alcohol"},{"key":"9655_CR142","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11606-002-0038-1","volume":"17","author":"R Malcolm","year":"2002","unstructured":"Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC (2002) The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 17:349\u2013350","journal-title":"J Gen Intern Med"},{"key":"9655_CR143","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(99)00393-3","volume":"377","author":"B Malinowska","year":"1999","unstructured":"Malinowska B, Napiorkowska-Pawlak D, Pawlak R, Buczko W, Gothert M (1999) Ifenprodil influences changes in mouse behaviour related to acute and chronic ethanol administration. Eur J Pharmacol 377:13\u201319","journal-title":"Eur J Pharmacol"},{"key":"9655_CR144","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biopsych.2012.10.020","volume":"73","author":"K Mann","year":"2013","unstructured":"Mann K, Bladstrom A, Torup L, Gual A, van den Brink W (2013) Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry 73:706\u2013713","journal-title":"Biol Psychiatry"},{"key":"9655_CR146","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10550490902772785","volume":"18","author":"P Mannelli","year":"2009","unstructured":"Mannelli P, Patkar AA, Peindl K, Gottheil E, Wu LT, Gorelick DA (2009) Early outcomes following low dose naltrexone enhancement of opiod detoxificaion. Am J Addict 18:109\u2013116","journal-title":"Am J Addict"},{"key":"9655_CR147","doi-asserted-by":"crossref","unstructured":"Marshall K, Gowing L, Ali R, Le Foll B (2014) Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev 12:CD008940","DOI":"10.1002\/14651858.CD008940.pub2"},{"key":"9655_CR148","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/JCP.0000000000000228","volume":"34","author":"G Martinotti","year":"2014","unstructured":"Martinotti G, Di Nicola M, De Vita O et al (2014) Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study. J Clin Psychopharmacol 34:709\u2013715","journal-title":"J Clin Psychopharmacol"},{"key":"9655_CR149","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.euroneuro.2003.08.009","volume":"13","author":"BJ Mason","year":"2003","unstructured":"Mason BJ (2003) Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment. Eur Neuropsychopharmacol 13:469\u2013475","journal-title":"Eur Neuropsychopharmacol"},{"key":"9655_CR150","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1530-0277.1994.tb00098.x","volume":"18","author":"BJ Mason","year":"1994","unstructured":"Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E (1994) A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res 18:1162\u20131167","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR151","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archpsyc.56.8.719","volume":"56","author":"BJ Mason","year":"1999","unstructured":"Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB (1999) A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56:719\u2013724","journal-title":"Arch Gen Psychiatry"},{"key":"9655_CR152","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1369-1600.2008.00133.x","volume":"14","author":"BJ Mason","year":"2009","unstructured":"Mason BJ, Light JM, Williams LD, Drobes DJ (2009) Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addict Biol 14:73\u201383","journal-title":"Addict Biol"},{"key":"9655_CR153","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/npp.2012.14","volume":"37","author":"BJ Mason","year":"2012","unstructured":"Mason BJ, Crean R, Goodell V et al (2012) A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology 37:1689\u20131698","journal-title":"Neuropsychopharmacology"},{"key":"9655_CR154","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","volume":"174","author":"BJ Mason","year":"2014","unstructured":"Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A (2014) Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med 174:70\u201377","journal-title":"JAMA Intern Med"},{"key":"9655_CR155","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jama.1997.03550020076042","volume":"278","author":"MF Mayo-Smith","year":"1997","unstructured":"Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278:144\u2013151","journal-title":"JAMA"},{"key":"9655_CR156","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/archinte.164.13.1405","volume":"164","author":"MF Mayo-Smith","year":"2004","unstructured":"Mayo-Smith MF, Beecher LH, Fischer TL et al (2004) Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 164:1405\u20131412","journal-title":"Arch Intern Med"},{"key":"9655_CR157","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/00003246-200006000-00014","volume":"28","author":"C McCowan","year":"2000","unstructured":"McCowan C, Marik P (2000) Refractory delirium tremens treated with propofol: a case series. Crit Care Med 28:1781\u20131784","journal-title":"Crit Care Med"},{"key":"9655_CR158","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jnnp.2007.128322","volume":"79","author":"A McKeon","year":"2008","unstructured":"McKeon A, Frye MA, Delanty N (2008) The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry 79:854\u2013862","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9655_CR159","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/10550490600860635","volume":"15","author":"AL McRae","year":"2006","unstructured":"McRae AL, Brady KT, Carter RE (2006) Buspirone for treatment of marijuana dependence: a\u00a0pilot study. Am J Addict 15:404","journal-title":"Am J Addict"},{"key":"9655_CR160","first-page":"3","volume":"73","author":"A Michalak","year":"2016","unstructured":"Michalak A, Bia\u0142a G (2016) Alcohol dependence - neurobiology and treatment. Acta Pol Pharm 73:3\u201312","journal-title":"Acta Pol Pharm"},{"key":"9655_CR161","first-page":"51","volume-title":"Pharmacological effects of ethanol on the nervous system","author":"SJ Mihic","year":"1996","unstructured":"Mihic SJ, Harris RA (1996) Alcohol actions at the GABAA receptor\/Chloride channel complex. In: Deitrich RA, Erwin VG (eds) Pharmacological effects of ethanol on the nervous system. CRC Press, Boca Raton, pp 51\u201372"},{"key":"9655_CR162","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40429-016-0098-7","volume":"3","author":"R Miranda Jr","year":"2016","unstructured":"Miranda R Jr, Treloar H (2016) Emerging pharmacologic treatments for adolescent substance use: challenges and new directions. Curr Addict Rep 3:145\u2013156","journal-title":"Curr Addict Rep"},{"key":"9655_CR163","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12350","author":"R Miranda Jr","year":"2016","unstructured":"Miranda R Jr, Treloar H, Blanchard A et al (2016) Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study. Addict Biol. doi: 10.1111\/adb.12350 [Epub ahead of print]","journal-title":"Addict Biol"},{"key":"9655_CR164","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/0140-6736(91)92903-F","volume":"337","author":"N Moore","year":"1991","unstructured":"Moore N, Libert C (1991) Acamprosate, citalopram, and alcoholism. Lancet 337:1228","journal-title":"Lancet"},{"key":"9655_CR165","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1360-0443.2006.01555.x","volume":"101","author":"KC Morley","year":"2006","unstructured":"Morley KC, Teesson M, Reid SC et al (2006) Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 101:1451\u20131462","journal-title":"Addiction"},{"key":"9655_CR166","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/00952990.2012.677889","volume":"39","author":"J Mutschler","year":"2013","unstructured":"Mutschler J, Eifler S, Dirican G, Grosshans M, Kiefer F, R\u00f6ssler W, Diehl A (2013) Functional social support within a medical supervised outpatient treatment program. Am J Drug Alcohol Abuse 39:44\u201349","journal-title":"Am J Drug Alcohol Abuse"},{"key":"9655_CR167","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1530-0277.2009.00986.x","volume":"33","author":"H Myrick","year":"2009","unstructured":"Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL (2009) A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res 33:1582\u20131588","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR168","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ADM.0b013e31828e1881","volume":"7","author":"N Nacca","year":"2013","unstructured":"Nacca N, Vatti D, Sullivan R, Sud P, Su M, Marraffa J (2013) The synthetic cannabinoid withdrawal syndrome. J Addict Med 7:296\u2013298","journal-title":"J Addict Med"},{"key":"9655_CR169","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/157015908783769662","volume":"6","author":"J Nagy","year":"2008","unstructured":"Nagy J (2008) Alcohol related changes in regulation of NMDA receptor functions. Curr Neuropharmacol 6:39\u201354","journal-title":"Curr Neuropharmacol"},{"key":"9655_CR170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2010.03.033","volume":"68","author":"SB Nanjayya","year":"2010","unstructured":"Nanjayya SB, Shivappa M, Chand PK, Murthy P, Benegal V (2010) Baclofen in cannabis dependence syndrome. Biol Psychiatry 68:9\u201310","journal-title":"Biol Psychiatry"},{"key":"9655_CR171","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","volume":"21","author":"M Navarro","year":"2001","unstructured":"Navarro M, Carrera MR, Fratta W et al (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21:5344\u20135350","journal-title":"J Neurosci"},{"key":"9655_CR172","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/0959523031000154436","volume":"22","author":"H Niederhofer","year":"2003","unstructured":"Niederhofer H, Staffen W (2003) Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug Alcohol Rev 22:295\u2013297","journal-title":"Drug Alcohol Rev"},{"key":"9655_CR173","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/1355621961000124956","volume":"1","author":"EP Noble","year":"1996","unstructured":"Noble EP (1996) Alcoholism and the dopaminergic system: a review. Addict Biol 1:333\u2013348","journal-title":"Addict Biol"},{"key":"9655_CR174","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1345\/aph.1L157","volume":"42","author":"CL Olmsted","year":"2008","unstructured":"Olmsted CL, Kockler DR (2008) Topiramate for alcohol dependence. Ann Pharmacother 42:1475\u20131480","journal-title":"Ann Pharmacother"},{"key":"9655_CR175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0028-3908(94)00133-D","volume":"34","author":"H Ovadia","year":"1995","unstructured":"Ovadia H, Wohlman A, Mechoulam R, Weidenfeld J (1995) Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology 34:175\u2013180","journal-title":"Neuropharmacology"},{"key":"9655_CR176","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00213-003-1425-y","volume":"167","author":"DH Overstreet","year":"2003","unstructured":"Overstreet DH, Knapp DJ, Moy SS, Breese GR (2003) A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Psychopharmacology 167:344\u2013352","journal-title":"Psychopharmacology"},{"key":"9655_CR177","first-page":"215","volume":"20","author":"SC Pandey","year":"1995","unstructured":"Pandey SC, Davis JM, Pandey GN (1995) Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates. J Psych Neurosci 20:215\u2013225","journal-title":"J Psych Neurosci"},{"key":"9655_CR178","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-244X-11-41","volume":"11","author":"T Paparrigopoulos","year":"2011","unstructured":"Paparrigopoulos T, Tzavellas E, Karaiskos D, Kourlaba G, Liappas I (2011) Treatment of alcohol dependence with low-dose topiramate. BMC Psychiatry 11:41","journal-title":"BMC Psychiatry"},{"key":"9655_CR179","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.disamonth.2014.05.003","volume":"60","author":"G Patel","year":"2014","unstructured":"Patel G (2014) The management of substance abuse in the critically ill. Dis Mon 60:429\u2013441","journal-title":"Dis Mon"},{"key":"9655_CR180","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jflm.2013.11.002","volume":"21","author":"BN Patra","year":"2014","unstructured":"Patra BN, Sharma A, Mehra A, Singh S (2014) Complicated alcohol withdrawal presenting as self mutilation. J Forensic Leg Med 21:46\u201347","journal-title":"J Forensic Leg Med"},{"key":"9655_CR181","first-page":"485","volume":"27","author":"RG Pertwee","year":"1988","unstructured":"Pertwee RG, Greentree SG (1988) Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide. Neuropsychopharmacology 27:485\u2013491","journal-title":"Neuropsychopharmacology"},{"key":"9655_CR182","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0091-3057(91)90366-A","volume":"40","author":"RG Pertwee","year":"1991","unstructured":"Pertwee RG, Browne SE, Ross TM, Stretton CD (1991) An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav 40:581\u2013585","journal-title":"Pharmacol Biochem Behav"},{"key":"9655_CR183","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/ijerph7041392","volume":"7","author":"M Pompili","year":"2010","unstructured":"Pompili M, Serafini G, Innamorati M, Dominici G, Ferracuti S, Kotzalidis GD et al (2010) Suicidal behavior and alcohol abuse. Int J Environ Res Public Health 7:1392\u20131431","journal-title":"Int J Environ Res Public Health"},{"key":"9655_CR184","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/070674370404901020","volume":"49","author":"S Potvin","year":"2004","unstructured":"Potvin S, Stip E, Roy JY (2004) The effects of quetiapine on cannabis use in 8 psychosis petients with drug dependency. Can J Psychiatry 49:711","journal-title":"Can J Psychiatry"},{"key":"9655_CR185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02244975","volume":"107","author":"WR Prescott","year":"1992","unstructured":"Prescott WR, Gold LH, Martin BR (1992) Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat. Psychopharmacology 107:117\u2013124","journal-title":"Psychopharmacology"},{"key":"9655_CR186","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10550490902927785","volume":"18","author":"WN Raby","year":"2009","unstructured":"Raby WN, Carpenter KC, Rothenberg J et al (2009) Intermittent marijuana use in associated with improved retention of naltrexone treatment for opiate-dependence. Am J Addict 18:301\u2013308","journal-title":"Am J Addict"},{"key":"9655_CR187","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajp.2013.05.003","volume":"6","author":"V Rajmohan","year":"2013","unstructured":"Rajmohan V, Sushil K, Mohandas E (2013) A double blind randomised comparison of chlordiazepoxide and lorazepam in alcohol withdrawal. Asian J Psychiatry 6:401\u2013403","journal-title":"Asian J Psychiatry"},{"key":"9655_CR188","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1017\/S1461145711001830","volume":"15","author":"M Ranganathan","year":"2012","unstructured":"Ranganathan M, Carbuto M, Braley G et al (2012) Naltrexone does not attenuate the effects of intravenous \u03949-tetrahydrocannabinol in healthy humans. Int J Neuropsychopharmacol 15:1251\u20131264","journal-title":"Int J Neuropsychopharmacol"},{"key":"9655_CR189","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1553-2712.2002.tb02171.x","volume":"9","author":"NK Rathlev","year":"2002","unstructured":"Rathlev NK, Ulrich A, Shieh TC, Callum MG, Bernstein E, D\u2019Onofrio G (2002) Etiology and weekly occurrence of alcohol-related seizures. Acad Emerg Med 9:824\u2013828","journal-title":"Acad Emerg Med"},{"key":"9655_CR190","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4103\/0253-7613.135947","volume":"46","author":"VK Reddy","year":"2014","unstructured":"Reddy VK, Girish K, Lakshmi P, Vijendra R, Kumar A, Harsha R (2014) Cost-effectiveness analysis of baclofen and chlordiazepoxide in uncomplicated alcohol-withdrawal syndrome. Indian J Pharmacol 46:372\u2013377","journal-title":"Indian J Pharmacol"},{"key":"9655_CR191","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1360-0443.2008.02215.x","volume":"103","author":"K Richardson","year":"2008","unstructured":"Richardson K, Baillie A, Reid S et al (2008) Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction 103:953\u2013959","journal-title":"Addiction"},{"key":"9655_CR192","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0447.1981.tb00781.x","volume":"64","author":"E Ritola","year":"1981","unstructured":"Ritola E, Malinen L (1981) A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 64:254\u2013259","journal-title":"Acta Psychiatr Scand"},{"key":"9655_CR193","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jemermed.2012.07.056","volume":"44","author":"J Rosenson","year":"2013","unstructured":"Rosenson J, Clements C, Simon B et al (2013) Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. J Emerg Med 44:592\u2013598","journal-title":"J Emerg Med"},{"key":"9655_CR194","doi-asserted-by":"crossref","unstructured":"Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev CD001867","DOI":"10.1002\/14651858.CD001867.pub3"},{"key":"9655_CR195","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1111\/j.1365-2125.1984.tb02581.x","volume":"18","author":"T Roth","year":"1984","unstructured":"Roth T, Roehrs T, Witig R, Zorick F (1984) Benzodiazepines and emory. Br J Clin Pharmacol 18:45S\u201349S","journal-title":"Br J Clin Pharmacol"},{"key":"9655_CR196","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2004-815473","volume":"37","author":"G Rubio","year":"2004","unstructured":"Rubio G, Ponce G, Jimenez-Arriero MA, Palomo T, Manzanares J, Ferre F (2004) Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry 37:37\u201340","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"9655_CR197","first-page":"VE01","volume":"9","author":"A Sachdeva","year":"2015","unstructured":"Sachdeva A, Choudhary M, Chandra M (2015) Alcohol Withdrawal syndrome: benzodiazepines and beyond. J Clin Diagn Res 9(9):VE01\u2013VE07","journal-title":"J Clin Diagn Res"},{"key":"9655_CR198","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1523\/JNEUROSCI.4394-15.2016","volume":"36","author":"AG Schindler","year":"2016","unstructured":"Schindler AG, Soden ME, Zweifel LS, Clark JJ (2016) Reversal of alcohol-induced dysregulation in dopamine network dynamics may rescue maladaptive decision-making. J Neurosci 36:3698\u20133708","journal-title":"J Neurosci"},{"key":"9655_CR199","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1060028016629161","volume":"50","author":"KJ Schmidt","year":"2016","unstructured":"Schmidt KJ, Doshi MR, Holzhausen JM, Natavio A, Cadiz M, Winegardner JE (2016) Treatment of Severe Alcohol Withdrawal. Ann Pharmacother 50:389\u2013401","journal-title":"Ann Pharmacother"},{"key":"9655_CR200","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.15288\/jsa.1977.38.2096","volume":"38","author":"EM Sellers","year":"1977","unstructured":"Sellers EM, Zilm DH, Degani NC (1977) Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J Stud Alcohol 38:2096\u20132108","journal-title":"J Stud Alcohol"},{"key":"9655_CR201","doi-asserted-by":"crossref","first-page":"e87366","DOI":"10.1371\/journal.pone.0087366","volume":"9","author":"MD Skinner","year":"2014","unstructured":"Skinner MD, Lahmek P, Pham H, Aubin HJ (2014) Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PLoS ONE 9:e87366","journal-title":"PLoS ONE"},{"key":"9655_CR202","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s00213-004-2118-x","volume":"179","author":"M Solinas","year":"2005","unstructured":"Solinas M, Goldberg SR (2005) Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats. Psychopharmacology 179:804\u2013812","journal-title":"Psychopharmacology"},{"key":"9655_CR203","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00406-006-0644-8","volume":"256","author":"M Soyka","year":"2006","unstructured":"Soyka M, Schmidt P, Franz M et al (2006) Treatment of alcohol withdrawal syndrome with a combination of tiapride\/carbamazepine: results of a pooled analysis in 540 patients. Eur Arch Psychiatry Clin Neurosci 256:395\u2013401","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"9655_CR204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(96)00175-6","volume":"305","author":"R Spanagel","year":"1996","unstructured":"Spanagel R, Putzke J, Stefferl A, Schobitz B, Zieglgansberger W (1996) Acamprosate and alcohol: iI. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 305:45\u201350","journal-title":"Eur J Pharmacol"},{"key":"9655_CR205","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/npp.2013.264","volume":"39","author":"R Spanagel","year":"2014","unstructured":"Spanagel R, Vengeliene V, Jandeleit B et al (2014) Acamprosate produces its anti-relapse effects via calcium. Neuropsychopharmacology 39:783\u2013791","journal-title":"Neuropsychopharmacology"},{"key":"9655_CR206","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1073\/pnas.0705368104","volume":"104","author":"P Steensland","year":"2007","unstructured":"Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE (2007) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci USA 104:12518\u201312523","journal-title":"Proc Natl Acad Sci USA"},{"key":"9655_CR207","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1345\/aph.1R751","volume":"47","author":"CJ Stock","year":"2013","unstructured":"Stock CJ, Carpenter L, Ying J, Greene T (2013) Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother 47:961\u2013969","journal-title":"Ann Pharmacother"},{"key":"9655_CR208","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00426599","volume":"52","author":"A Sulkowski","year":"1977","unstructured":"Sulkowski A, Vachon L, Rich ES Jr (1977) Propranolol effects on acute marihuana intoxication in man. Psychopharmacology 52:47\u201353","journal-title":"Psychopharmacology"},{"key":"9655_CR209","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199905133401907","volume":"340","author":"RM Swift","year":"1999","unstructured":"Swift RM (1999) Drug therapy for alcohol dependence. N Engl J Med 340:1482\u20131490","journal-title":"N Engl J Med"},{"key":"9655_CR210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/ajad.12346","volume":"25","author":"LG Sylvia","year":"2016","unstructured":"Sylvia LG, Gold AK, Stange JP et al (2016) Brief report: a randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder. Am J Addict 25:94\u201398","journal-title":"Am J Addict"},{"key":"9655_CR211","first-page":"447","volume":"105","author":"G Testino","year":"2014","unstructured":"Testino G, Leone S, Borro P (2014) Treatment of alcohol dependence: recent progress and reduction of consumption. Minerva Med 105:447\u2013466","journal-title":"Minerva Med"},{"key":"9655_CR212","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0149-7634(85)90035-1","volume":"9","author":"MH Thi\u00e9bot","year":"1985","unstructured":"Thi\u00e9bot MH (1985) Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci Biobehav Rev 9:95\u2013100","journal-title":"Neurosci Biobehav Rev"},{"key":"9655_CR213","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bmj.318.7194.1311","volume":"318","author":"H Tonnesen","year":"1999","unstructured":"Tonnesen H, Rosenberg J, Nielsen HJ, Rasmussen V, Hauge C, Pedersen IK, Kehlet H (1999) Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ 318:1311\u20131316","journal-title":"BMJ"},{"key":"9655_CR214","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(81)90217-X","volume":"70","author":"FC Tulunay","year":"1981","unstructured":"Tulunay FC, Ayhan IH, Portoghese PS, Takemori AE (1981) Antagonism by chlornaltrexamine of some effects of \u03949-tetrahydrocannabinol in rats. Eur J Pharmacol 70:219\u2013224","journal-title":"Eur J Pharmacol"},{"key":"9655_CR215","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/08039481003686180","volume":"64","author":"J Ulrichsen","year":"2010","unstructured":"Ulrichsen J, Nielsen MK, Ulrichsen M (2010) Disulfiram in severe alcoholism\u2013an open controlled study. Nord J Psychiatry 64:356\u2013362","journal-title":"Nord J Psychiatry"},{"key":"9655_CR216","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/npp.2010.253","volume":"36","author":"JC Umhau","year":"2011","unstructured":"Umhau JC, Schwandt ML, Usala J, Geyer C, Singley E, George DT, Heilig M (2011) Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 36:1178\u20131186","journal-title":"Neuropsychopharmacology"},{"key":"9655_CR217","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0024-3205(97)00922-3","volume":"61","author":"IT Uzbay","year":"1997","unstructured":"Uzbay IT, Erden BF, Tapanyigit EE, Kayaalp SO (1997) Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci 61:2197\u20132209","journal-title":"Life Sci"},{"key":"9655_CR218","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjp.2008.30","volume":"154","author":"V Vengeliene","year":"2008","unstructured":"Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154:299\u2013315","journal-title":"Br J Pharmacol"},{"key":"9655_CR219","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0376-8716(99)00127-1","volume":"59","author":"SR Wachtel","year":"2000","unstructured":"Wachtel SR, de Wit H (2000) Naltrexone doses not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans. Drug Alcohol Depend 59:251\u2013260","journal-title":"Drug Alcohol Depend"},{"key":"9655_CR220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.alcohol.2007.12.002","volume":"42","author":"BM Walker","year":"2008","unstructured":"Walker BM, Rasmussen DD, Raskind MA, Koob GF (2008) Alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 42:91\u201397","journal-title":"Alcohol"},{"key":"9655_CR221","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02244856","volume":"114","author":"WP Watson","year":"1994","unstructured":"Watson WP, Little HJ (1994) Interactions between diltiazem and ethanol: differences from those seen with dihydropyridine calcium channel antagonists. Psychopharmacology 114:329\u2013336","journal-title":"Psychopharmacology"},{"key":"9655_CR222","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(02)02236-9","volume":"930","author":"WP Watson","year":"2002","unstructured":"Watson WP, Little HJ (2002) Selectivity of the protective effects of dihydropyridine calcium channel antagonists against the ethanol withdrawal syndrome. Brain Res 930:111\u2013122","journal-title":"Brain Res"},{"key":"9655_CR223","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/j.1476-5381.1991.tb09845.x","volume":"103","author":"MA Whittington","year":"1991","unstructured":"Whittington MA, Dolin SJ, Patch TL, Siarey RJ, Butterworth AR, Little HJ (1991) Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment. Br J Pharmacol 103:1669\u20131676","journal-title":"Br J Pharmacol"},{"key":"9655_CR224","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00702-005-0333-1","volume":"113","author":"J Wilhelm","year":"2006","unstructured":"Wilhelm J, Bayerlein K, Hillemacher T et al (2006) Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism. J Neural Transm 113:357\u2013363","journal-title":"J Neural Transm"},{"key":"9655_CR225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/00952999409084061","volume":"20","author":"TM Worner","year":"1994","unstructured":"Worner TM (1994) Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial. Am J Drug Alcohol Abuse 20:115\u2013124","journal-title":"Am J Drug Alcohol Abuse"},{"key":"9655_CR226","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/acer.12278","volume":"38","author":"A Yoshimura","year":"2014","unstructured":"Yoshimura A, Kimura M, Nakayama H et al (2014) Efficacy of disulfiram for the treatment of alcohol dependence assessed with a multicenter randomized controlled trial. Alcohol Clin Exp Res 38:572\u2013578","journal-title":"Alcohol Clin Exp Res"},{"key":"9655_CR227","first-page":"885","volume":"118","author":"CW Zwilich","year":"1978","unstructured":"Zwilich CW, Doekel R, Hammill S, Weil JV (1978) The effects of smoked marijuana on metabolism and respiratory control. Am Rev Respir Dis 118:885\u2013891","journal-title":"Am Rev Respir Dis"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-016-9655-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-016-9655-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-016-9655-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T12:56:59Z","timestamp":1692449819000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-016-9655-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":225,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["9655"],"URL":"https:\/\/doi.org\/10.1007\/s12640-016-9655-z","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]}}}